|
MechanismHIV-1 integrase inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CA |
First Approval Date21 Sep 2020 |
100 Clinical Results associated with ViiV Healthcare GmbH
0 Patents (Medical) associated with ViiV Healthcare GmbH
100 Deals associated with ViiV Healthcare GmbH
100 Translational Medicine associated with ViiV Healthcare GmbH